Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The procedure accurately measures 5-alpha-dihydrotestosterone in blood, useful for standard tests.

DA-9401 can protect against finasteride-induced reproductive damage in rats.

High DHA levels delay wound healing and worsen skin repair quality.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Deucravacitinib effectively treats psoriasis and may help with other skin conditions.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

DHEA inhibits growth in both mouse and human melanoma cells but works differently in each.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

A new compound that could treat various androgen-related conditions was created and analyzed.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Tridax procumbens parts have antioxidant properties.

Cooling the scalp below 22°C before and during chemotherapy can help prevent hair loss.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

Analog 23 is a promising compound for prostate cancer treatment.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

Divalproex sodium can cause pleural effusion, which stops when the drug is discontinued.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

The combination of encorafenib and binimetinib caused few skin issues.